AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2018

Feb 16, 2018

30870_dirs_2018-02-16_9159d3ba-0cb1-4647-b8c8-896f4bca99ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2018-02-08

Reporting Person: RODDY PETER S (SVP Finance & CAO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1520	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Incentive Stock Option (right to buy)	$16.4	2027-04-28	Common Stock (22458)		Direct
Non-Qualified Stock Option (right to buy)	$16.4	2027-04-28	Common Stock (27542)		Direct

Footnotes

F1: When the ISO and NQ dated 04/28/17 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 12,500 shares on 04/28/18 and the balance of 37,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 04/28/21.